scispace - formally typeset
Open AccessBook

Polymorphism in Pharmaceutical Solids

TLDR
Brittain et al. as mentioned in this paper applied the phase rule to the characterisation of polymorphic and solvatomorphic systems, and proposed a computational method to predict polymorphism.
Abstract
THERMODYNAMIC AND THEORETICAL ISSUES Theory and Principles of Polymorphic Systems, Harry G. Brittain Application of the Phase Rule to the Characterization of Polymorphic and Solvatomorphic Systems, Harry G. Brittain Computational Methodologies: Toward Crystal Structure and Polymorph Prediction, Sarah (Sally) L. Price PREPARATIVE METHODS FOR POLYMORPHS AND SOLVATOMORPHS Classical Methods of Preparation of Polymorphs and Alternative Solid Forms, Peter W. Cains Approaches to High-Throughput Physical Form Screening and Discovery, Alastair J. Florence STRUCTURAL PROPERTIES OF POLYMORPHS AND SOLVATOMORPHS Structural Aspects of Polymorphism, Harry G. Brittain, Stephen R. Byrn, and Eunhee Lee Structural Aspects of Solvatomorphic Systems, Harry G. Brittain, Kenneth R. Morris, and Stephan X. M. Boerrigter Pharmaceutical Co-crystals: A New Opportunity in Pharmaceutical Science for a Long-Known but Little-Studied Class of Compounds, Kapildev K. Arora and Michael J. Zaworotko CHARACTERIZATION METHODS FOR POLYMORPHS AND SOLVATOMORPHS Thermoanalytical and Crystallographic Methods, Sisir Bhattacharya, Harry G. Brittain, and Raj Suryanarayanan Vibrational Spectroscopy, Harry G. Brittain Solid-State Nuclear Magnetic Resonance Spectroscopy, Patrick A. Tishmack Effects of Polymorphism and Solid-State Solvation on Solubility and Dissolution Rate, Harry G. Brittain, David J. R. Grant, and Paul B. Myrdal INTERCONVERSION OF POLYMORPHS AND SOLVATOMORPHS Solid-State Phase Transformations, Harry G. Brittain Effects of Pharmaceutical Processing on the Solid Form of Drug and Excipient Materials, Peter L. D. Wildfong SPECIAL TOPICS RELATED TO POLYMORPHISM AND SOLVATOMORPHISM Structural Aspects of Molecular Dissymmetry, Harry G. Brittain Amorphous Solids, Lynne S. Taylor and Sheri L. Shamblin Index

read more

Citations
More filters
Journal ArticleDOI

Amorphous pharmaceutical solids: preparation, characterization and stabilization.

TL;DR: Current research in the stabilization of amorphous solids focuses on the stabilize of labile substances during processing and storage using additives, the prevention of crystallization of the excipients that must remainAmorphous for their intended functions, and the selection of appropriate storage conditions under which amorphously solids are stable.
Journal ArticleDOI

What is the true solubility advantage for amorphous pharmaceuticals

TL;DR: Amorphous pharmaceuticals are markedly more soluble than their crystalline counterparts, however, their experimental solubility advantage is typically less than that predicted from simplethermodynamic considerations.
Journal ArticleDOI

High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids

TL;DR: The impact of form diversity encompasses issues of stability and bioavailability, as well as development considerations such as process definition, formulation design, patent protection and regulatory control.
Journal Article

Dry powder inhaler formulation.

TL;DR: This review focuses on the dry powder inhaler (DPI) formulation and development process, which involves micronized drug blended with larger carrier particles, which enhance flow, reduce aggregation, and aid in dispersion.
Journal ArticleDOI

When poor solubility becomes an issue: From early stage to proof of concept ☆

TL;DR: The conference focused specifically on the impact of compounds with poor solubility on analytical evaluation, prediction of oral absorption, substance selection, material and formulation strategies and development.